Company Filing History:
Years Active: 2015
Title: Innovations in Diabetes Treatment by Ryan John Hansen
Introduction
Ryan John Hansen is an accomplished inventor based in Riverton, UT (US). He has made significant contributions to the field of diabetes through his innovative work on PEGylated insulin lispro compounds. His research focuses on improving the efficacy and duration of insulin treatments for diabetes patients.
Latest Patents
Ryan John Hansen holds a patent for PEGylated insulin lispro compounds. This invention relates to the field of diabetes and involves compounds that are PEGylated with high molecular weight poly(ethylene glycol). These compounds are highly soluble at physiological pH and have an extended duration of action. They are characterized by pharmacokinetic, pharmacodynamic, and/or activity peak-trough ratios of less than 2. The invention also encompasses methods for providing such molecules, pharmaceutical compositions containing them, and their therapeutic uses.
Career Highlights
Ryan John Hansen is associated with Eli Lilly and Company, where he continues to work on advancements in diabetes treatment. His innovative approach has the potential to significantly improve the quality of life for individuals living with diabetes.
Collaborations
Ryan has collaborated with notable coworkers, including John Michael Beals and Gordon Butler Cutler, Jr. These collaborations have further enhanced the development of his innovative solutions in diabetes care.
Conclusion
Ryan John Hansen's contributions to diabetes treatment through his patent on PEGylated insulin lispro compounds exemplify the impact of innovation in healthcare. His work continues to pave the way for improved therapeutic options for diabetes patients.